RIZZO, Giacomo Emanuele Maria
 Distribuzione geografica
Continente #
NA - Nord America 528
EU - Europa 204
AS - Asia 70
AF - Africa 2
Totale 804
Nazione #
US - Stati Uniti d'America 528
IT - Italia 146
SG - Singapore 48
DE - Germania 22
CN - Cina 15
GB - Regno Unito 12
IE - Irlanda 9
FI - Finlandia 5
IN - India 4
RU - Federazione Russa 4
CI - Costa d'Avorio 2
JP - Giappone 2
SE - Svezia 2
BE - Belgio 1
GR - Grecia 1
HK - Hong Kong 1
NL - Olanda 1
RO - Romania 1
Totale 804
Città #
Chandler 107
Fairfield 58
Ashburn 47
Singapore 39
Houston 26
Medford 23
Seattle 23
Woodbridge 23
Altamura 22
Wilmington 20
Palermo 17
New York 16
Cambridge 15
Lawrence 13
Princeton 13
Bremen 12
Dublin 9
Ann Arbor 7
Milan 6
Rome 6
San Diego 6
Beijing 5
Foggia 5
London 5
Venice 5
Appignano 4
Des Moines 4
Trapani 4
Bologna 3
Florence 3
Piacenza 3
Pune 3
Saint Petersburg 3
Abidjan 2
Catania 2
Cologne 2
Columbus 2
Erice 2
Fasano 2
Grassobbio 2
Helsinki 2
Lappeenranta 2
Leawood 2
Los Angeles 2
Ludwigshafen am Rhein 2
Mercato San Severino 2
Novellara 2
San Benedetto del Tronto 2
San Giorgio di Piano 2
San Paolo di Civitate 2
Santa Clara 2
Tokyo 2
Washington 2
Bagheria 1
Boardman 1
Brussels 1
Central 1
Chiswick 1
Clifton 1
Corridonia 1
Dallas 1
Favara 1
Forest City 1
Fremont 1
Gallarate 1
Guangzhou 1
Hanover 1
Hebei 1
Islington 1
Jiaxing 1
Kemerovo 1
Melfi 1
Munich 1
Nanjing 1
Napoli 1
Newark 1
Ningbo 1
Norwalk 1
Oderzo 1
Pisa 1
Quanzhou 1
Rieti 1
San Francisco 1
Tulsa 1
Uhlingen-Birkendorf 1
Utrecht 1
Xi'an 1
Zhengzhou 1
Totale 630
Nome #
An evaluation score of the difficulty of thyroidectomy considering operating time and preservation of recurrent laryngeal nerve 144
Optimizing sequential systemic therapies for advanced hepatocellular carcinoma: A decision analysis 114
Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma 85
The changing scenario of hepatocellular carcinoma in Italy: an update 76
Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization? 67
Ketogenic diet, physical activity, and hypertension—a narrative review 58
Systemic therapies for hepatocellular carcinoma: The present and the future 53
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 48
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis 47
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials 45
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 36
SARS-CoV-2 infection in patients with a normal or abnormal liver 35
Pattern of macrovascular invasion in hepatocellular carcinoma 31
Hepatitis B Virus-Associated Hepatocellular Carcinoma 30
Balancing Efficacy and Tolerability of First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis 20
What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg-negative anti-HBc-positive patients? Meta-analysis and decision curve analysis 17
Totale 906
Categoria #
all - tutte 5.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202033 0 0 0 0 7 5 7 4 4 4 2 0
2020/2021101 3 0 13 0 16 4 5 0 22 4 22 12
2021/2022203 25 17 10 5 3 4 3 34 36 9 30 27
2022/2023295 19 61 5 41 28 42 2 21 52 7 7 10
2023/2024153 7 20 4 14 4 49 14 3 2 7 11 18
2024/202576 4 10 18 33 11 0 0 0 0 0 0 0
Totale 906